Authors
Loading...
Systematic review reveals total metabolic tumor volume is a key prognostic biomarker for progression-free survival in follicular lymphoma, highlighting its clinical significance.
Chovatiya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: